Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Smoking Cessation | 17 | 2025 | 395 | 4.310 |
Why?
|
Stress Disorders, Post-Traumatic | 5 | 2020 | 68 | 1.990 |
Why?
|
Cyclonic Storms | 4 | 2019 | 5 | 1.960 |
Why?
|
Motivation | 9 | 2025 | 207 | 1.940 |
Why?
|
Smokers | 6 | 2022 | 124 | 1.810 |
Why?
|
Smoking | 9 | 2022 | 465 | 1.720 |
Why?
|
Substance-Related Disorders | 4 | 2022 | 166 | 1.460 |
Why?
|
Cigarette Smoking | 4 | 2020 | 76 | 1.350 |
Why?
|
Disasters | 3 | 2017 | 15 | 1.260 |
Why?
|
African Americans | 6 | 2022 | 350 | 1.240 |
Why?
|
Depression | 2 | 2019 | 210 | 1.100 |
Why?
|
Adolescent Behavior | 2 | 2017 | 67 | 1.080 |
Why?
|
Sexual and Gender Minorities | 2 | 2023 | 36 | 1.040 |
Why?
|
Telemedicine | 2 | 2025 | 135 | 1.010 |
Why?
|
Homeless Persons | 3 | 2022 | 113 | 1.000 |
Why?
|
Smartphone | 3 | 2024 | 58 | 1.000 |
Why?
|
Adult | 22 | 2025 | 7369 | 0.990 |
Why?
|
Stress, Psychological | 5 | 2021 | 209 | 0.990 |
Why?
|
Feasibility Studies | 2 | 2025 | 186 | 0.960 |
Why?
|
Mobile Applications | 2 | 2024 | 55 | 0.960 |
Why?
|
Prostate-Specific Antigen | 1 | 2024 | 51 | 0.950 |
Why?
|
Middle Aged | 17 | 2025 | 6807 | 0.900 |
Why?
|
Early Detection of Cancer | 1 | 2024 | 121 | 0.890 |
Why?
|
Pandemics | 2 | 2023 | 165 | 0.880 |
Why?
|
Tobacco Products | 5 | 2022 | 190 | 0.870 |
Why?
|
Male | 21 | 2025 | 12858 | 0.860 |
Why?
|
Exercise | 2 | 2025 | 451 | 0.860 |
Why?
|
Humans | 36 | 2025 | 26797 | 0.850 |
Why?
|
Marijuana Use | 3 | 2024 | 32 | 0.800 |
Why?
|
Tobacco Smoking | 2 | 2020 | 38 | 0.790 |
Why?
|
Prostatic Neoplasms | 1 | 2024 | 270 | 0.770 |
Why?
|
Female | 25 | 2025 | 14437 | 0.770 |
Why?
|
Self Efficacy | 2 | 2019 | 72 | 0.760 |
Why?
|
Sex Factors | 2 | 2019 | 444 | 0.740 |
Why?
|
Skin Pigmentation | 1 | 2019 | 10 | 0.680 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2020 | 40 | 0.680 |
Why?
|
Social Support | 6 | 2021 | 122 | 0.680 |
Why?
|
Tobacco Use Disorder | 2 | 2019 | 115 | 0.670 |
Why?
|
Attitude | 1 | 2019 | 42 | 0.630 |
Why?
|
Pain | 1 | 2021 | 252 | 0.610 |
Why?
|
Self Medication | 1 | 2017 | 4 | 0.600 |
Why?
|
Problem Behavior | 1 | 2017 | 14 | 0.580 |
Why?
|
Religion | 1 | 2016 | 23 | 0.550 |
Why?
|
Tobacco Use | 1 | 2017 | 83 | 0.550 |
Why?
|
Urban Population | 1 | 2016 | 70 | 0.540 |
Why?
|
Alcohol Drinking | 1 | 2017 | 162 | 0.520 |
Why?
|
Health Status Disparities | 1 | 2016 | 60 | 0.500 |
Why?
|
Adolescent | 8 | 2023 | 2952 | 0.500 |
Why?
|
New Orleans | 4 | 2019 | 4 | 0.490 |
Why?
|
Recurrence | 6 | 2021 | 315 | 0.480 |
Why?
|
Tennessee | 2 | 2019 | 25 | 0.320 |
Why?
|
Social Class | 2 | 2019 | 78 | 0.320 |
Why?
|
Methamphetamine | 2 | 2020 | 20 | 0.310 |
Why?
|
Vulnerable Populations | 3 | 2024 | 46 | 0.310 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2024 | 357 | 0.280 |
Why?
|
Pilot Projects | 2 | 2024 | 387 | 0.250 |
Why?
|
Prospective Studies | 2 | 2019 | 1216 | 0.250 |
Why?
|
Ecological Momentary Assessment | 3 | 2021 | 47 | 0.250 |
Why?
|
Aged | 4 | 2024 | 5158 | 0.250 |
Why?
|
Risk Factors | 3 | 2019 | 2009 | 0.240 |
Why?
|
Surveys and Questionnaires | 4 | 2024 | 916 | 0.230 |
Why?
|
Suicidal Ideation | 1 | 2023 | 5 | 0.230 |
Why?
|
Suicide, Attempted | 1 | 2023 | 11 | 0.230 |
Why?
|
Sexual Behavior | 2 | 2022 | 87 | 0.220 |
Why?
|
United States | 3 | 2020 | 2030 | 0.220 |
Why?
|
Health Promotion | 1 | 2025 | 169 | 0.210 |
Why?
|
Nicotine | 2 | 2021 | 82 | 0.210 |
Why?
|
Life Change Events | 2 | 2020 | 33 | 0.200 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2024 | 279 | 0.200 |
Why?
|
Young Adult | 5 | 2022 | 2576 | 0.200 |
Why?
|
Menthol | 1 | 2022 | 18 | 0.200 |
Why?
|
Triple Negative Breast Neoplasms | 1 | 2022 | 32 | 0.190 |
Why?
|
Atmosphere | 1 | 2021 | 8 | 0.190 |
Why?
|
Quality of Life | 1 | 2024 | 462 | 0.180 |
Why?
|
Cross-Sectional Studies | 3 | 2020 | 909 | 0.180 |
Why?
|
Mental Health | 2 | 2022 | 96 | 0.180 |
Why?
|
Self Report | 1 | 2021 | 116 | 0.180 |
Why?
|
Risk-Taking | 1 | 2020 | 57 | 0.180 |
Why?
|
Missouri | 1 | 2019 | 9 | 0.170 |
Why?
|
Machine Learning | 1 | 2020 | 78 | 0.170 |
Why?
|
Anxiety Disorders | 1 | 2020 | 59 | 0.170 |
Why?
|
Unemployment | 1 | 2019 | 6 | 0.170 |
Why?
|
Cues | 1 | 2019 | 38 | 0.170 |
Why?
|
Safety-net Providers | 1 | 2019 | 14 | 0.160 |
Why?
|
Medically Uninsured | 1 | 2019 | 30 | 0.160 |
Why?
|
Perinatal Care | 1 | 2018 | 4 | 0.160 |
Why?
|
Employment | 1 | 2019 | 45 | 0.160 |
Why?
|
Texas | 1 | 2019 | 133 | 0.160 |
Why?
|
Depressive Disorder, Major | 1 | 2020 | 125 | 0.160 |
Why?
|
Survivors | 1 | 2018 | 36 | 0.160 |
Why?
|
Linear Models | 1 | 2019 | 202 | 0.160 |
Why?
|
Vaping | 1 | 2021 | 122 | 0.160 |
Why?
|
Social Theory | 1 | 2017 | 1 | 0.150 |
Why?
|
MicroRNAs | 1 | 2022 | 280 | 0.150 |
Why?
|
Protective Factors | 1 | 2017 | 16 | 0.150 |
Why?
|
Leisure Activities | 1 | 2017 | 15 | 0.150 |
Why?
|
Psychological Theory | 1 | 2017 | 29 | 0.150 |
Why?
|
Electronic Nicotine Delivery Systems | 1 | 2021 | 193 | 0.140 |
Why?
|
Adaptation, Psychological | 1 | 2017 | 117 | 0.140 |
Why?
|
Models, Theoretical | 1 | 2017 | 129 | 0.140 |
Why?
|
Age Factors | 1 | 2019 | 714 | 0.140 |
Why?
|
Amphetamine-Related Disorders | 1 | 2016 | 16 | 0.140 |
Why?
|
Fear | 1 | 2016 | 58 | 0.140 |
Why?
|
Depressive Disorder | 1 | 2016 | 53 | 0.130 |
Why?
|
Disease Susceptibility | 1 | 2016 | 72 | 0.130 |
Why?
|
Neoplasms | 1 | 2024 | 748 | 0.130 |
Why?
|
Health Services Needs and Demand | 1 | 2015 | 36 | 0.130 |
Why?
|
Longitudinal Studies | 1 | 2016 | 400 | 0.120 |
Why?
|
Tobacco | 1 | 2015 | 86 | 0.120 |
Why?
|
Child | 1 | 2017 | 2141 | 0.090 |
Why?
|
Poverty | 2 | 2024 | 81 | 0.090 |
Why?
|
Pregnancy | 2 | 2020 | 1127 | 0.060 |
Why?
|
Cannabis | 1 | 2024 | 41 | 0.060 |
Why?
|
Gender Identity | 1 | 2022 | 20 | 0.050 |
Why?
|
Educational Status | 1 | 2022 | 110 | 0.050 |
Why?
|
Adenosine Triphosphate | 1 | 2022 | 115 | 0.050 |
Why?
|
Counseling | 1 | 2022 | 51 | 0.050 |
Why?
|
Administration, Cutaneous | 1 | 2021 | 18 | 0.050 |
Why?
|
Smoking Prevention | 1 | 2021 | 87 | 0.050 |
Why?
|
Guilt | 1 | 2020 | 5 | 0.050 |
Why?
|
Shame | 1 | 2020 | 6 | 0.050 |
Why?
|
Postpartum Period | 1 | 2020 | 63 | 0.040 |
Why?
|
Population Surveillance | 1 | 2020 | 85 | 0.040 |
Why?
|
Odds Ratio | 1 | 2020 | 231 | 0.040 |
Why?
|
Internet | 1 | 2020 | 121 | 0.040 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2020 | 96 | 0.040 |
Why?
|
Logistic Models | 1 | 2020 | 399 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2022 | 441 | 0.040 |
Why?
|
Health Behavior | 1 | 2020 | 153 | 0.040 |
Why?
|
Risk Assessment | 1 | 2020 | 586 | 0.040 |
Why?
|
Grounded Theory | 1 | 2016 | 13 | 0.040 |
Why?
|
Attitude to Death | 1 | 2016 | 13 | 0.040 |
Why?
|
Oklahoma | 1 | 2020 | 970 | 0.030 |
Why?
|
Self Concept | 1 | 2016 | 52 | 0.030 |
Why?
|
Empirical Research | 1 | 2015 | 5 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2015 | 2262 | 0.020 |
Why?
|